AtaiBeckley Inc (ATAI) Stock Analysis
Verdict: HOLD
Eli Lilly's $3.8B acquisition caps upside at ~$7.50; ATAI is now a merger arbitrage play with limited alpha remains for retail investors.
Investment score: 62/100
Analysis as of
Is AtaiBeckley Inc stock worth reviewing? The TradeMates thesis
ATAI has shifted from a speculative biotech to a deal-arbitrage play following the Eli Lilly takeover bid. With price targets lowered to $7.50 and the stock at $7.16, the remaining 4.7% upside is standard for merger spreads but unattractive for risk-seeking capital.
7-factor investment score
- Valuation: 40/100 (weight 20%)
- Financial Health: 70/100 (weight 15%)
- Technical Momentum: 95/100 (weight 15%)
- Earnings Quality: 50/100 (weight 15%)
- Insider Sentiment: 35/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 75/100 (weight 15%)
AtaiBeckley Inc opportunities and risks
What speaks for ATAI
- Eli Lilly Strategic Backing
What speaks against ATAI
- Deal Break Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ATAI | n/a | 754.2x | n/a | 82.0% | -19019.4% | -4.5% |
| CURA.TO | n/a | 1.9x | 18.2x | 40.8% | -7.9% | 2.2% |
| GPCR | n/a | 0.0x | n/a | 0.0% | 0.0% | -5.9% |
| MBX | n/a | 0.0x | n/a | 0.0% | 0.0% | -3.9% |
| SUPN | n/a | 3.6x | 51.3x | 89.4% | -3.7% | 2.9% |
| TRVI | n/a | 0.0x | n/a | 0.0% | 0.0% | -1.2% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -1.2% |
Frequently asked questions about AtaiBeckley Inc (ATAI)
Is ATAI stock a good investment?
The TradeMates model rates AtaiBeckley Inc as HOLD with an investment score of 62/100. ATAI has shifted from a speculative biotech to a deal-arbitrage play following the Eli Lilly takeover bid. With price targets lowered to $7.50 and the stock at $7.16, the remaining 4.7% upside is standard for merger spreads but unattractive for risk-seeking capital. This is algorithmic model output, not personal investment advice.
Is ATAI stock a buy?
The TradeMates model verdict for ATAI is HOLD with an investment score of 62/100. Treat this as a model signal to review, not a personal buy recommendation.